Exact Sciences Corp at Barclays Global Healthcare Conference Transcript
I'm Jack Meehan, the life science tools and diagnostics analyst at Barclays, and really thrilled to be hosting Exact Sciences and CFO, Jeff Elliott.
I also have Megan Jones from the Investor Relations team here. So before we kick it off, we're going to do 3 audience response questions. So use the blackberry-type devices. Question one, what do you view as Exact's organic growth rate over the next 3-year period? So CAGR will get to the -- we use the same question for every company, but we'll see if they agree on the growth.
(Voting)
Might have needed a higher double-digit range, 64%.
Number two, do you expect organic growth to accelerate from these levels and when? What is your organic growth rate forecast for '19?
It's in the double digits. Okay. So it got to be better
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
